NETRF BOSA Leadership Transition The Neuroendocrine Tumor Research Foundation is pleased to share updates on the leadership and membership of its Board of Scientific Advisors
By Anna C. Greene, PhD | NETRF Chief Scientific Officer In May, I attended the 2026 Small Cell Lung Cancer Consortium hosted by the National
By Udhayvir Singh Grewal, MD GI/Neuroendocrine Medical Oncologist and Assistant Professor of Medical Oncology, Winship Cancer Institute of Emory University School of Medicine Dr. Grewal contributed
By Anna C. Greene, PhD, NETRF Chief Scientific Officer At the Neuroendocrine Tumor Research Foundation (NETRF), we fund research that can change how neuroendocrine cancers
Neuroendocrine neoplasms (NENs) can be difficult to detect, and many patients face long delays before receiving an accurate diagnosis. In many cases, NENs are not
By Carrie Camino, Member, NETRF Board of Directors Last month I had the extraordinary opportunity to attend the American Association of Cancer Research (AACR) as
By Anna C. Greene, PhD, NETRF Chief Scientific Officer The American Association for Cancer Research Annual Meeting, known as AACR, is one of the largest
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Two recent NETRF-funded studies are offering new insight into how neuroendocrine tumors grow, spread, and respond
At the Neuroendocrine Tumor Research Foundation (NETRF), we support research that can move the field forward, not only by advancing new treatments, but also by
By Anna C. Greene, PhD, NETRF Chief Scientific Officer A new multi-institutional study provides one of the most comprehensive pictures to date of what life